 |
|
||
| Avandia Lawyers | Cases | ||
November 14, 2007—The FDA ordered that a black box warning be added to Avandia, alerting patients to cardiovascular risks. The move comes nearly six months after The New England Journal of Medicine published an article questioning the safety of the pharmaceutical. The agency further announced that it has asked GlaxoSmithKline, the drug's manufacturer, to conduct long-term studies comparing the risks of Avandia to other oral antidiabetic medications. |
|||
| Study Demonstrates Avandia Increases Risk of Heart Attack | Contact Us | ||
May 22, 2007—The New England Journal of Medicine published an article concluding that Avandia substantially increases the risk of heart attacks, compared to other diabetes drugs or a placebo. The article reviewed more than 40 clinical studies involving 28,000 patients. Dr. Steven Nissen, the lead reviewer, estimated that tens of thousands of people experienced heart attacks as a result of their taking Avandia. GlaxoSmithKline had been aware of these problems since at least August 2006, when a similar analysis conducted by its experts revealed the same type of risk. Notwithstanding substantial data detailing the unfavorable health risk, GlaxoSmithKline defends the safety of Avandia and claims the drug has a comparable cardiovascular profile to competing oral antidiabetic medications. |
|||
| Our Lawyers Can Help You | Avandia News | ||
Winder & Haslam presently is investigating legal claims against the manufacturer of Avandia. We invite you to contact us for a free, confidential consultation about your legal rights. We will represent Avandia patients throughout the United States. We can help you, too, wherever you live. If you or a loved one has suffered heart problems while taking Avandia, please contact us immediately. |
FDA Issues Strictest Warnings on Diabetes Drugs Doctor Says Drug Maker Tried to Quash His Criticism of Avandia Senator Says FDA Was Lax on Label for Avandia |
||
|
|||
